View Cart
Microbix Logo
Request Catalogue Contact Us
Contact Us

Leading Infectious Disease Biomaterial Manufacturer

  • Copan FLOQSwab® and Liquid Control Products
    • Clinical Diagnostics,
    • Proficiency Programs,
    • Training, Verification and Development
  • Antigens for Diagnostic Test Manufacturers
  • Viral Transport Medium – DxTM™
VTM? – LEARN MORE

Microbix Reports Results for H1 & Q2 2026

H1 Revenues of $7.6 million and Controlled Net Loss   MISSISSAUGA, CANADA, May 14, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,…

Read More

Microbix Schedules Release of Results for Q2 Fiscal 2026

Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.

Read More

Microbix Product Results Being Presented at 2026 PASCV

Microbix announces announces it will be attending and presenting at the 2026 Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Centre, North Building, on April 21 and 22, 2026.

Read More

QAPS

Why choose Microbix Quality Assessment Products (QAPs)? Find out more.

INFECTIOUS DISEASE ANTIGENS

Microbix produces one of the world’s broadest range of infectious disease antigens.

PARTNERSHIP OPPORTUNITIES

Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.